← Human Trials & Peer-Reviewed Studies
Plasma cholecystokinin is associated with subjective measures of satiety in women
Plain-language guide to PMID 12198015 (2002): crossover randomized controlled trial study of Cholecystokinin (CCK) in 7 men.
Key Facts
- PMID
- 12198015
- Journal
- The American journal of clinical nutrition
- Year
- 2002
- Study type
- Randomized Controlled Trial
- Authors
- Burton-Freeman B et al. (3 authors)
- DOI
- 10.1093/ajcn/76.3.659
What This Study Did, in Plain Language
What Was Tested
Researchers studied Cholecystokinin (CCK) in this randomized controlled trial publication.
Visual analogue scales were used to assess subjects' hunger, desire to eat, fullness, and prospective consumption.
Why It Was Studied
Fat stimulates cholecystokinin release, and fiber appears to prolong cholecystokinin elevation during the alimentary period.
Who Took Part
The study group was 7 men.
PubMed indexes the participants as adults and middle-aged adults, both men and women.
Blood samples were drawn from fasted subjects (7 men and 8 women) before and at different time points after test meal consumption for 6 h.
How the Study Was Run
In design terms this was a randomized and crossover study.
Random assignment meant chance, not the researchers, decided who got Cholecystokinin (CCK) and who got the comparison, which limits bias.
Each person switched between Cholecystokinin (CCK) and the comparison at some point, usually with a gap in between.
Three isoenergetic breakfast meals were tested in a randomized crossover design: low fiber, low fat; high fiber, low fat; and low fiber, high fat.
Plasma was analyzed for cholecystokinin, insulin, glucose, and triacylglycerols.
What Was Measured
Topics PubMed links to this paper include Blood Glucose, Cholecystokinin, Diet Records, Dietary Fats, Dietary Fiber, Eating and Energy Intake.
What This Means in Plain Language
The paper is a randomized and crossover study of Cholecystokinin (CCK) in 7 men.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2002 (The American journal of clinical nutrition), a journal based in United States.
More context: the Cholecystokinin (CCK) compound page, all human trials.
Our Notes on the Compound
Cholecystokinin (CCK): A gut and brain peptide hormone that stimulates gallbladder contraction and signals fullness.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.